The present study also suggests that enhancing the volume-dependent effect on circulating ANP concentrations in volume-dependent hypertension, using neprilysin inhibitors, may be a more effective approach to preventing the transition to heart failure in patients with hypertensive heart disease caused by volume-dependent hypertension. Here, NPPA is linked to heart failure.